Composition containing poria cocos peel extract for treating neurodegenerative disorders
Abstract
The present invention relates to a pharmaceutical composition and a food composition for preventing or ameliorating degenerative neurological disease comprising Poria cocos peel extract for preventing, or treating neurodegenerative disorders. Poria cocos peel extract which is the active ingredients contained in the composition of the present invention, has a memory ameliorating activity through inhibiting of acetylcholine esterase and a neuroprotective effect and neuron protection by inhibiting the formation of beta amyloid and tau phosphorylation and promoting NGF production. Thus, the present invention may be useful as a pharmaceutical composition for preventing or treating degenerative neurological diseases, or as a health food for the above purpose.
Claims
exact text as granted — not AI-modified1 . A method for preventing or treating a degenerative neurological disease, comprising Poria cocos peel extract as an active ingredient.
2 . The method of claim 1 , wherein the degenerative neurological disease is selected from the group consisting of Alzheimer's Dementia, Creutzfeldt-Jakob disease, Huntington's disease, multiple sclerosis, Guilin-Barre syndrome, Parkinson's disease, Lou Gehrig's disease, progressive dementia caused by gradual neuronal death and progressive Ataxia.
3 .- 11 . (canceled)
12 . A pharmaceutical composition comprising Poria cocos peel extract as an active ingredient, wherein the extract does not comprise Poria cocos WOLF or Jeokboryoung.
13 . The pharmaceutical composition of claim 12 , wherein the extract of Poria cocos peel is in an amount of from 10 to 90% by weight based on the total weight of the composition.
14 . The pharmaceutical composition of claim 12 , further comprising a suitable carrier, excipient or diluent selected from the group consisting of lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil.
15 . The pharmaceutical composition of claim 12 , wherein the composition comprises:
(a) 100 mg of the extract; (b) 3.0 mg of sodium metabisulfite; (c) 0.8 mg of methylparaben; and (d) 0.1 mg of propylparaben; wherein the composition is in an injectable form.
16 . The pharmaceutical composition of claim 12 , wherein the composition comprises:
(a) 200 mg of the extract; (b) 100 mg of lactose; (c) 100 mg of starch; and (d) a pharmaceutically acceptable amount of magnesium stearate; wherein the composition is in a tablet form.
17 . The pharmaceutical composition of claim 12 , wherein the composition comprises:
(a) 100 mg of the extract; (b) 50 mg of lactose; (c) 100 mg of starch; (d) 2 mg of talc; and (e) a pharmaceutically acceptable amount of magnesium stearate; wherein the composition is in a capsule form.
18 . The pharmaceutical composition of claim 12 , wherein the composition comprises:
(a) 1000 mg of the extract; (b) 20 g of sugar; (c) 20 g of high fructose corn; and (d) a pharmaceutically acceptable amount of lemon incense; wherein the composition is in a liquid form.
19 . A method of preparing a pharmaceutical composition, the method comprising:
(a) obtaining washed and dried Poria cocos peel; (b) preparing a mixture by adding water, alcohol, or a mixture of water and alcohol to the Poria cocos peel; and (b) subjecting the mixture to extraction at a temperature of 10° C. to 100° C. for 1 to 72 hours.
20 . The method of claim 19 , wherein the Poria cocos peel extract is extracted with water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof.
21 . The method of claim 19 , wherein the Poria cocos peel extract is extracted with 60 to 80 (v/v) % of ethanol.Join the waitlist — get patent alerts
Track US2021128656A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.